Clinical Trials Browser

Phase 3 × apixaban × 30 days × Clear all

NCT07493304 2026-03-25

ROXI-CAT-II

Phase 3 Not yet recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism